本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Fortress Biotech Inc Series A P

9.15
+0.41004.69%
盤後9.470.3199+3.50%16:23 EDT
成交量:4.95萬
成交額:46.06萬
市值:3,135.80萬
市盈率:-4.17
高:9.70
開:9.10
低:9.00
收:8.74
52周最高:9.85
52周最低:4.72
股本:342.71萬
流通股本:342.71萬
量比:1.31
換手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-2.1959
每股收益(LYR):-2.6890
淨資產收益率:-746.25%
總資產收益率:-32.37%
市淨率:1.41
市盈率(LYR):-3.40

資料載入中...

2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/27

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/19

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

SEC問詢函

Form CORRESP - Correspondence
2023/07/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/23

重要事件披露

Form 8-K - Current report